🔓 Unlock the full profile of Daniel Geffken (Danforth Advisors), including verified contact details, financial insights, and professional associations.
See Daniel Geffken Full Profile 💼 Explore Live Investment DealsFrom IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: dan*****@dan******.com
Mobile: 95989*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Daniel Geffken is the Founder and Managing Director of Danforth Advisors, established in August 2011, a firm specializing in providing financial consulting services to life sciences companies.
- Under Daniel's leadership, Danforth Advisors has gained a reputation for offering strategic financial guidance to startups and established biopharmaceutical companies.
- Daniel Geffken also serves as the Interim Chief Financial Officer at Eloxx Pharmaceuticals since April 2021, contributing financial oversight during critical periods of the company's growth.
- In addition to the role at Eloxx Pharmaceuticals, Daniel is actively serving as a Senior Financial Advisor at Olaris, Inc, and Affini-T, showcasing versatility across multiple organizations.
- Daniel has taken the role of Chief Financial Officer at Locust Walk Acquisition Corp. since December 2020, further expanding expertise in the financial sector.
- Throughout the years, Daniel has faced challenges of market dynamics and financial regulations, continually adapting strategies that drive success in the biotech sector.
- Daniel's extensive career reflects a commitment to advancing financial practices within the life sciences industry, aiding startups in navigating the complexities of funding and growth.
- The network and partnerships developed through Danforth Advisors bolster opportunities for clients, creating impactful connections within the industry.
- With a focus on client-centered financial solutions, Daniel Geffken has positioned Danforth Advisors as a vital resource for emerging companies seeking to optimize their financial health.